ALG1 p.Met382Ile
c.1146G>A · rs778368053 · VCV1483545
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9645 | likely pathogenic · top 8% in ALG1 |
|---|---|---|
| REVEL | 0.932 | strongly pathogenic-leaning |
| SaProt | LLR -13.01 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>C here scores Δ0.28 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 7.5 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 1.27 | unconstrained · MANE · 13 kb · p 3.2e-11 · regional, not allelic |
| Overall | ||
| CADD | 29.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.00156% | 64,006 |
| European (non-Finnish)grpmax | 0.0011% | 90,759 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ALG1
- Protein
- p.Met382Ile
- Coding
- c.1146G>A
- MANE Select
- NM_019109
- dbSNP
- rs778368053
- Type
- single nucleotide variant
- Location
- chr16:5082632 (GRCh38)
- Gene constraint
- LOEUF 1.419 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 93.24
- Residue 382
- a UniProt-annotated variant site (in cdg1k; decreased function in protein glycosylation as shown by rescue assays in an alg1-deficient yeast strain)
Disease context
ALG1-congenital disorder of glycosylation — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: congenital disorder of glycosylation
For ALG1-CDG (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- ALG1 p.Met382Thr Pathogenic/Likely pathogenic ★★ same residue
- ALG1 p.Met382Val Likely pathogenic ★★ same residue
- ALG1 p.Met382Lys Likely pathogenic same residue
- ALG1 c.1187+1G>A Pathogenic/Likely pathogenic ★★ same condition
- ALG1 c.1187+2T>C Pathogenic ★★ same condition
- ALG1 c.1188-2A>G Pathogenic/Likely pathogenic ★★ same condition
- ALG1 c.209-2A>G Likely pathogenic ★★ same condition
- ALG1 c.539+1G>A Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/alg1-p-met382ile (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown